Menu Search
Equities

Top Glove Corporation Bhd

TOPGLOV:KLS

Top Glove Corporation Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)1.10
  • Today's Change0.00 / 0.00%
  • Shares traded7.11m
  • 1 Year change+46.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy2
Outperform5
Hold6
Sell4
Strong Sell2

Share price forecast in MYR

The 18 analysts offering 12 month price targets for Top Glove Corporation Bhd have a median target of 1.08, with a high estimate of 1.40 and a low estimate of 0.71. The median estimate represents a -2.27% decrease from the last price of 1.10.
High27.3%1.40
Med-2.3%1.08
Low-35.5%0.71

Dividends in MYR

Historical dividend information is not available for Top Glove Corporation Bhd.
Div growth (TTM)--
More ▼

Earnings history & estimates in MYR

On Oct 10, 2024, Top Glove Corporation Bhd reported 4th quarter 2024 breakeven earnings per share. This result was in line with the expectation of the one analyst following the company and outperformed last year's 4th quarter results by 0.058.
The next earnings announcement is expected on Dec 18, 2024.
Average growth rate+0.74%
Top Glove Corporation Bhd reported annual 2024 losses of -0.008 per share on Oct 10, 2024.
Average growth rate+105.87%
More ▼

Revenue history & estimates in MYR

Top Glove Corporation Bhd. had 4th quarter 2024 revenues of 835.31m. This bettered the 725.61m estimate of the one analyst covering the company. This was 32.06% above the prior year's 4th quarter results.
Average growth rate+15.53%
Top Glove Corporation Bhd. had revenues for the full year 2024 of 2.52bn. This was 11.47% above the prior year's results.
Average growth rate+3.16%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.